Literature DB >> 23385785

Evolution of complex palatomaxillary reconstructions: the scapular angle osteomuscular free flap.

Cesare Piazza1, Alberto Paderno, Valentina Taglietti, Piero Nicolai.   

Abstract

PURPOSE OF REVIEW: This review summarizes the worldwide experience (105 patients) in primary and secondary reconstruction of palatomaxillary oncologic defects with the angular branch-based subscapular system of free flaps, comparing the advantages and disadvantages of the technique with those of other well known osseous donor sites such as the fibula and iliac crest. RECENT
FINDINGS: The most recognized indications for angular branch-based osteomuscular free flaps are class II (especially in association with zygomaticomaxillary buttress and/or floor of the orbit removal) and class III defects according to the Okay classification. Defects involving clearance of the orbital content have also been reconstructed in this manner. One of the most important drawbacks of this technique (i.e., need for intraoperative patient repositioning) is no longer considered an issue, and evidence has been provided that harvesting of angular branch-based scapular flaps may be routinely performed in a supine position. Three-dimensional morphologic similarity of the tip of the scapula with the native hard palate and other maxillary structures makes flap fabrication easy and practical, with at least two (horizontal and vertical) most commonly used flap orientations applied to reconstruct different defects.
SUMMARY: Angular branch-based osteomuscular scapular free flaps represent a major advance in palatomaxillary reconstruction: their versatility, long pedicle with large caliber donor vessels, morphologic similarity with maxillary bony structures, and limited donor-site morbidity compare favorably with those of other osteomuscular and osteomusculocutaneous free flaps described for such challenging reconstructive purposes.

Entities:  

Mesh:

Year:  2013        PMID: 23385785     DOI: 10.1097/MOO.0b013e32835e8445

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  7 in total

Review 1.  Palatomaxillary Reconstruction: Fibula or Scapula.

Authors:  Arvind K Badhey; Mohemmed N Khan
Journal:  Semin Plast Surg       Date:  2020-05-06       Impact factor: 2.314

2.  Scapular Tip Free Flap for Head and Neck Reconstruction.

Authors:  Nayeon Choi; Jae-Keun Cho; Jeon Yeob Jang; Jung Kyu Cho; Young Sang Cho; Chung-Hwan Baek
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-11-10       Impact factor: 3.372

3.  Palato-maxillary reconstruction by the angular branch-based tip of scapula free flap.

Authors:  Cesare Piazza; Alberto Paderno; Francesca Del Bon; Valentina Taglietti; Alberto Grammatica; Nausica Montalto; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-18       Impact factor: 2.503

4.  Sandwich Fascial Anterolateral Thigh Flap in Head and Neck Reconstruction: Evolution or Revolution?

Authors:  Mario Cherubino; Jens Berli; Mario Turri-Zanoni; Paolo Battaglia; Francesca Maggiulli; Martina Corno; Federico Tamborini; Edoardo Montrasio; Paolo Castelnuovo; Luigi Valdatta
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-01-17

5.  Midfacial Reconstruction - A Systematic Review.

Authors:  Aala Emara; Adel Abou ElFetouh; Maha Hakam; Basma Mostafa
Journal:  Open Access Maced J Med Sci       Date:  2016-06-17

6.  Osteocutaneous flaps for head and neck reconstruction: A focused evaluation of donor site morbidity and patient reported outcome measures in different reconstruction options.

Authors:  Marie Kearns; Panagiotis Ermogenous; Simon Myers; Ali Mahmoud Ghanem
Journal:  Arch Plast Surg       Date:  2018-11-15

7.  Donor Site Morbidity and Quality of Life after Microvascular Head and Neck Reconstruction with a Chimeric, Thoracodorsal, Perforator-Scapular Flap Based on the Angular Artery (TDAP-Scap-aa Flap).

Authors:  Jürgen Wallner; Marcus Rieder; Michael Schwaiger; Bernhard Remschmidt; Wolfgang Zemann; Mauro Pau
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.